Neurocognitive aspects of hyperparathyroidism
https://doi.org/10.14341/omet9507
Abstract
The clinical features of primary hyperparathyroidism (PHPT) are characterized not only by typical end organ damage, including osteopenia/osteoporosis, nephrocalcinosis/renal calculi, pancreatitis, but also by neurocognitive changes, including weakness, easy fatigability, depression, inability to concentrate, memory impairment or subtle deficits, dementia, anxiety, irritability and sleep disturbances. The indications for the surgical treatment of PHPT are markedly elevated serum calcium, end organ damage, younger patients (less than 50 years). Cardiovascular and neurocognitive complications of PHPT are not currently an indication for surgical treatment. The results of the surgical treatment of PHTP are contradictory for neurocognitive symptoms. Some studies have demonstrated an improvement in neurocognitive symptoms after parathyroidectomy (PTE), including patients with mild PHPT. However, randomized trials have not demonstrated the benefits of PTE in patients with mild PHPT for neurocognitive symptoms. There are certain difficulties at evaluation of neurocognitive manifestations of PHPT, and therefore, it is actual to use a specific quality of life questionnaire, assessing cognitive function and memory deficit of the patient. Considering the prevalence of patients with asymptomatic course of PHPT and the absence of typical clinical manifestations of the disease, but with the presence of neurocognitive symptoms, the question of the appropriateness of surgical intervention in such cases remains relevant.
About the Authors
Valeriya O. PoyarkovaI.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
student
Guzel E. Runova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
MD, PhD, assistant of the Department of Endocrinology, Faculty of Medicine
Valentin V. Fadeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
MD, ScD, professor, corresponding member of the Russian Academy of Sciences, head of the Department of Endocrinology, Director of the Endocrinology Clinic of the Medical Faculty
References
1. Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., и др. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения. // Проблемы эндокринологии. – 2016. – Т.62. – №6 – С. 40-77. [Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of endocrinology. 2016;62(6):40-77. (In Russ).] doi: 10.14341/probl201662640-77
2. Э. Фаучи, Ю. Браунвальд и др. Внутренние болезни по Тинсли Р. Харрисону. Книга 6. Эндокринные болезни и нарушения обмена веществ. – М.: Практика, 2005;13(3). [Fauci A.S., Braunwald E. et al. Harrison's Principles of Internal Medicine – Moscow: Praktika, 2005;13(3). (In Russ.)] doi: 10.1017/CBO9781107415324.004
3. Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017; 28(1):1-19. doi: 10.1007/s00198-016-3716-2
4. Kim L, Krause MW, Harris EL, Khardori R. Hyperparathyroidism. Medscape [Internet] 2017. Available at: https://emedicine.medscape.com/article/127351-overview Accessed December 9, 2018.
5. Mathur R, Stöppler MC. Hyperparathyroidism. emedicinehealth [Internet] 2015. Available at: https://www.emedicinehealth.com/hyperparathyroidism/article_em.htm Accessed December 9, 2018.
6. Delgado A, Legg TJ. Hyperparathyroidism. Healthline [Internet] 2016. Available at: https://www.healthline.com/health/hyperparathyroidism Accessed December 9, 2018.
7. Гречаный С.В., Минаков А.А.: Психические расстройства при гиперпаратиреозе. Психические расстройства в общей медицине.2013; 01:34-37. [Grechanyi S.V., Minakov A.A.: Psikhicheskie rasstroistva pri giperparatireoze. Psikhicheskie rasstroistva v obshchei meditsine.2013; 01:34-37. (In Russ).]
8. Goggins R, Emerson C, Nowers M. Othello Syndrome in association with Primary Hyperparathyroidism. Priory Medical Journals. [Internet] 2004. Available at: http://www.priory.com/psych/othello.htm Accessed December 9, 2018.
9. Tsukahara K, Sugitani I, Fujimoto Y, Kawabata K. Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Oto-Rhino-Laryngology. 2008; 265:565–569. doi: 10.1007/s00405-007-0523-6
10. Prasarttong-Osoth P, Wathanaoran P, Imruetaicharoenchoke W, Rojananin S. Primary hyperparathyroidism: 11-year experience in a Single Institute in Thailand. Int J Endocrinol. 2012. doi: 10.1155/2012/952426
11. Weber T, Keller M, Hense I, et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg. 2007; 31(6):1204-1211. doi: 10.1007/s00268-007-9006-6
12. Trombetti A, Christ ER, Henzen C, et al. Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. J Endocrinol Invest. 2016; 39:567–576. doi: 10.1007/s40618-015-0423-3
13. Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: A prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007; 92(8):3114–3121. doi: 10.1210/jc.2007-0219
14. Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: A prospective, randomized trial. J Clin Endocrinol Metab. 2007; 92(5):1687–1692. doi: 10.1210/jc.2006-1836
15. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004; 89(11):5415–5422. doi: 10.1210/jc.2004-0028
16. Walker MD, Silverberg SJ. Non-traditional Manifestations of Primary Hyperparathyroidism. The Parathyroids: Basic and Clinical Concepts: Third Edition. 2014; 469-480 doi: 10.1016/B978-0-12-397166-1.00032-1
17. Lourida I, Thompson-Coon J, Dickens CM, et al. Parathyroid hormone, cognitive function and dementia: A systematic review. PLoS One. 2015; 10(5). doi: 10.1371/journal.pone.0127574
18. Webb SM, Puig-Domingo M, Villabona C, Muñoz-Torres M, Farrerons J, Badia X. Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013; 11:97. doi: 10.1186/1477-7525-11-97
19. Wu JX, Yeh MW. Asymptomatic Primary Hyperparathyroidism. Diagnostic Pitfalls and Surgical Intervention. Surg Oncol Clin N Am.2016; 25:77–90. doi: 10.1016/j.soc.2015.08.004
20. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J Clin Endocrinol Metab.2014; 99(10):3561-3569. doi: 10.1210/jc.2014-1413
Supplementary files
Review
For citations:
Poyarkova V.O., Runova G.E., Fadeev V.V. Neurocognitive aspects of hyperparathyroidism. Obesity and metabolism. 2019;16(1):7-11. (In Russ.) https://doi.org/10.14341/omet9507
Views:
1520
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
